Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many patients wonder if they're heavy enough to qualify for semaglutide or Ozempic. The truth is that FDA-approved semaglutide (Ozempic, Wegovy) has no set weight threshold. Instead, eligibility depends on Body Mass Index (BMI), existing health conditions like type 2 diabetes, and clinical judgment from your healthcare provider.

Understanding Semaglutide Eligibility Beyond Weight

The FDA approval for Ozempic (semaglutide) focuses on BMI and metabolic health rather than absolute body weight. For weight management, Wegovy is indicated for individuals with a BMI of 30 or higher, or a BMI of 27 or higher with weight-related conditions such as high blood pressure, type 2 diabetes, or heart disease. However, your actual weight in pounds is less important than your BMI relative to your height and whether you have obesity-related health risks.

PlexusDx compounded semaglutide injection offers the same active ingredient as brand-name Ozempic and Wegovy, starting at $149 per month from licensed 503A compounding pharmacies. Your healthcare provider can evaluate whether you meet clinical criteria for semaglutide therapy based on your individual health profile, not a rigid weight cutoff. This personalized approach means someone at 180 pounds with metabolic dysfunction may benefit from therapy, while another person at 250 pounds might benefit differently depending on their unique physiology.

BMI vs. Weight: Why Numbers Tell Different Stories

Body Mass Index (BMI) is calculated as weight in kilograms divided by height in meters squared. A BMI of 25 to 29.9 is considered overweight; 30 and above is classified as obese. The reason BMI matters more than raw weight is that two people with the same weight can have very different health risks depending on their height and muscle composition. A 200-pound person who is 5'10" has a BMI of about 28.7 (overweight), while a 200-pound person who is 6'3" has a BMI of about 25 (normal weight).

Semaglutide's clinical benefits extend beyond simple weight reduction. GLP-1 receptor activation improves blood sugar control, reduces appetite signaling in the brain, and may lower cardiovascular risk. These benefits can apply to individuals with lower BMI values if they have metabolic risk factors like prediabetes, insulin resistance, or a strong family history of type 2 diabetes. Your provider evaluates your complete health picture rather than stopping at a scale reading.

Pre-Treatment Evaluation: What Providers Actually Check

Before starting semaglutide, your healthcare provider typically reviews your medical history, current medications, kidney and liver function, and personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN 2). Blood work often includes fasting glucose, HbA1c (average blood sugar over three months), lipid panel, and basic metabolic panel. These tests matter far more than stepping on a scale, because they reveal whether your body will respond well to GLP-1 therapy and whether any safety precautions are needed.

PlexusDx goes one step further with the optional Precision Peptide Genetic Test ($99 add-on after your first month). This test examines your genetic variants in pathways controlling appetite, metabolism, and peptide signaling—including the GLP-1 receptor gene itself. Genetic insights into 49 peptides across 14 metabolic pathways help predict your individual response to semaglutide and whether you might benefit from dual-compound therapy like GLP-Squared (semaglutide plus tirzepatide injection). This genetic layer of personalization addresses why two patients at the same weight respond differently to the same medication.

Starting Semaglutide: Dose Escalation and Price Certainty

Semaglutide therapy begins with a low dose (typically 0.25 mg weekly) and increases gradually over four to eight weeks to reach therapeutic levels (1.0 to 2.4 mg weekly). This gradual escalation allows your body to adapt, reduces nausea, and lets your provider find your optimal dose regardless of your starting weight. Heavier individuals sometimes require higher doses, but lighter individuals may achieve results at standard doses—again, this depends on metabolism and genetic factors, not weight alone.

PlexusDx's pricing model removes the anxiety of dose increases. Compounded semaglutide injection starts at $149 per month—flat. Whether your dose increases from 0.5 mg to 1.0 mg to 2.4 mg, your price stays the same. No per-dose upcharging, no tiered pricing based on medication volume. PlexusDx serves all 50 states with no insurance requirement, no membership fee, and HSA/FSA eligibility, making precision weight loss therapy accessible to those at any starting weight or body composition.

When Weight Alone Isn't the Full Story

Many patients qualify for semaglutide based on metabolic conditions rather than absolute weight. Someone with a BMI of 26 but prediabetes, high triglycerides, or a strong family history of type 2 diabetes may benefit from semaglutide's glucose-lowering and cardiovascular protective effects. Conversely, a person with BMI over 30 but no metabolic risk factors might pursue other strategies first. This nuance explains why your provider's clinical judgment—supported by lab work and health history—matters more than crossing an arbitrary weight threshold.

PlexusDx pharmacists and medical providers review your complete health context. Whether you choose compounded semaglutide injection ($149/mo), oral semaglutide ($249/mo), tirzepatide injection ($249/mo), or GLP-Squared dual-compound therapy, your eligibility and medication selection are based on metabolic science, not a scale number. The goal is sustainable weight loss paired with improved blood sugar control, cardiovascular health, and quality of life—outcomes that apply across a wide range of starting weights.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I have to weigh a certain amount to start semaglutide?

No. FDA-approved semaglutide requires a BMI of 30 or higher, or 27 or higher with weight-related health conditions—not a minimum body weight. PlexusDx evaluates your individual metabolic profile, lab values, and medical history to determine if semaglutide injection or other GLP-1 therapy is appropriate for you.

What if I'm only slightly overweight but have prediabetes?

You may still qualify for semaglutide therapy. GLP-1 receptor agonists like semaglutide improve insulin sensitivity and blood sugar control independent of significant weight loss. Your provider can recommend semaglutide or tirzepatide based on your metabolic needs rather than weight category alone.

Does my weight affect how much semaglutide costs?

No. PlexusDx compounded semaglutide injection starts at $149 per month flat—your dose may increase, but your price won't. This applies across all three commitment tiers, all 50 states, with no insurance needed and HSA/FSA eligibility.

Why do some people lose more weight than others on semaglutide?

Genetics, metabolism, adherence, lifestyle, and baseline insulin sensitivity all influence semaglutide response. PlexusDx's Precision Peptide Genetic Test identifies your genetic variants in GLP-1R, GIPR, FTO, and MC4R genes to predict your likely response and guide therapy selection.

How does PlexusDx personalize semaglutide therapy for different body types?

Beyond weight, PlexusDx considers your BMI, metabolic labs, medical history, and optional genetic testing across 49 peptide pathways. This precision approach ensures your semaglutide injection ($149/mo) or oral semaglutide ($249/mo) is tailored to your unique physiology, not a one-size-fits-all protocol.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves